OnCovid: natural history and outcomes of cancer patients during the COVID19 epidemic
The overarching purpose of this retrospective, non-interventional study is to describe the features of COVID-19 infection in cancer patients, investigate its severity in this population and evaluate long-term outcomes.
|Imperial PI||Dr David Pinato|
|Trial Sponsor||Imperial College London|
|Study status||Retrospective analysis|
Total participants to date
Database of 204 patients analysed
Since study inception on March 24th, the first interim analysis of a database of 204 cancer patients with Covid-19 has been completed, and the study opened to 8 centres in UK, Spain and Italy, with another 6 joining in the coming weeks.
Find out more about the the study, centres and latest news, here.